Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Treatment Options for Xerostomia (Dry Mouth)

Assessment and Diagnosis

  • Baseline evaluation of salivary gland function should be performed by measuring whole salivary flows, as subjective feelings of dryness may not match objective measurements 1
  • Rule out non-Sjögren's related conditions such as candidiasis and burning mouth syndrome 2
  • Consider salivary scintigraphy for more detailed assessment of gland function 1

Treatment Algorithm Based on Salivary Function

  • For patients with mild glandular dysfunction, non-pharmacological stimulation is the preferred first-line approach 2
  • Gustatory stimulants, such as sugar-free acidic candies, lozenges, and xylitol, can be used for non-pharmacological stimulation 1
  • Mechanical stimulants, such as sugar-free chewing gum, can also be used for non-pharmacological stimulation 1
  • The ideal preparation should have a neutral pH and contain fluoride and other electrolytes to mimic natural saliva 2
  • All non-pharmacological interventions provide some degree of subjective symptom relief, though evidence doesn't strongly favor one intervention over another 1
  • For patients with moderate glandular dysfunction, muscarinic agonists, such as pilocarpine, may be considered 2
  • Randomized controlled trials showed significant improvements in visual analogue scale dry mouth scores and salivary flow rates with muscarinic agonists 2
  • Cevimeline is another option with a potentially better tolerance profile, though it's not as widely licensed as pilocarpine 2
  • For patients with no salivary output, saliva substitution should be the preferred therapeutic approach 2
  • Saliva substitutes are commercially available and should mimic the composition of natural saliva 2

Special Considerations

Radiation-Induced Xerostomia

  • Amifostine (200 mg/m² IV) administered before radiation therapy has been shown to reduce both acute and chronic xerostomia in head and neck cancer patients 3, 4
  • Amifostine reduced grade 2 or higher acute xerostomia from 78% to 51% and chronic xerostomia from 57% to 34% at one year post-treatment 4
  • IMRT (Intensity-Modulated Radiation Therapy) significantly reduces xerostomia compared to conventional radiotherapy by sparing major salivary glands 5
  • Patients receiving IMRT had significantly lower rates of clinician-rated severe xerostomia (39.3% vs 82.1%) and higher salivary flow rates 5

ICU Patients with Thirst/Xerostomia

  • A "bundle" of thirst interventions including sprays of cold sterile water, swabs of cold sterile water, and mouth/lip moisturizers can significantly decrease thirst intensity and distress 6
  • Frozen gauze pads with normal saline or ice have been shown to be more effective than wet gauze for thirst relief 6
  • Avoid lemon-glycerin swabs as they produce acidic pH, dry oral tissues, cause enamel erosion, and exhaust salivary mechanisms 6
  • For non-intubated patients on oxygen therapy, heated humidifiers are better than bubble humidifiers for reducing mouth and throat dryness 6
  • Family members can be involved in providing oral care for patients unable to self-administer treatments 6